TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
LNTH

Lantheus Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

100.80$ +0.3% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Lantheus Holdings Inc (LNTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 388 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement LNTH
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
320 354 370 394 379 391 373 378 384 407 377 388 1,556
120 124 118 138 137 143 135 137 162 166 146 146 620
200 230 252 256 242 249 238 241 222 241 231 242 936
14 17 48 61 24 35 36 45 48 47 39 38 173
36 40 48 47 41 58 57 67 82 70 58 21 230
88 92 151 153 108 135 136 153 179 164 150 142 634
112 137 100 103 134 114 102 88 44 77 81 100 302
5.1 5.0 4.9 4.9 4.9 5.0 4.8 4.9 5.0 5.1 4.9 4.9 20
160 138 171 84 176 -0.8 97 105 42 70 156 94 363
28 35 40 22 45 11 24 26 15 16 38 19 88
132 103 131 62 131 -12 73 79 28 54 118 75 275
180 158 192 104 198 22 115 123 68 98 184 115 465

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?